1: Principles of Pharm Flashcards

1
Q

Pharmacokinetics

A

study of how a drug is absorbed, distributed, or eliminated from the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

threshold dose

A

minimum dose of a drug needed to cause cellular changes (aka minimal effective dose)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

potency / potent

A

amount of a drug needed to produce a given effect / powerful in small doses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

pharmacotherapeutics

A

drugs used to prevent, treat, or diagnose a disease (therapeutic impact of medications)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

pharmacodynamics

A

analysis of what the drug does to the body at the systemic and cellular level (what is the effect of the drug on the body)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What group monitors and approves new drugs in the U.S.?

A

the FDA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

how are animals involved in the drug creation process?

A

they are the initial testing phase, before human tests

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are the 3 phases of drug testing (number of subjects)?

A

Phase 1 - 10-100 subjects
Phase 2 - 50-500
Phase 3 - hundreds to thousands

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What portion of drugs tested in clinical trails reach the marketplace?

A

less than 1/3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

controlled substances

A

medications with strict regulations in order to try to prevent drug abuse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

drug toxicity

A

drug level exceeds therapeutic range; body reacts to higher rate of intake before the body can metabolize or excrete

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

TI equation

A

TD50 / ED50

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

non-receptor drugs

A

some drugs exert their effects without interaction with a receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

neurotransmitters

A

released by neurons to cause excitation or inhibition to other neurons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

ceiling effect

A

maximum dose of a drug where increased doses will not result in further change

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

median effective dose (ED50)

A

the dose at which 50% of the population responds to it in the expected manner

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

median toxic dose (TD50)

A

the dose at which 50% of the population exhibits the specific adverse effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

median lethal dose (LD50)

A

the dose that causes death in 50% of the animals it was tested on

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

therapeutic index

A

an indicator of the drug’s safety; determined by the median effective dose and toxic dose. safer drugs have higher TI value (larger margin for error)

20
Q

drugs with highest vs. lowest TI

A

highest: OTC
lowest: chemo

21
Q

enteral drug administration

A

drug intake that involves the GI system; oral, sublingual, buccal, rectal

22
Q

parental drug administration

A

drug intake that is not associated with the GI system; inhalation, injection, topical, transdermal

23
Q

oral administration

A
  • swallowing drug, absorbed by GI lumen
  • most common enteral method
  • must be lipid-soluble so that it is absorbed into mucosa and bloodstream
  • may be slower and less complete than some parenteral routes
24
Q

first-pass effect

A

when a significant amount of the drug is metabolized by the liver before it ever reaches its site of action

25
Q

sublingual and buccal administration

A
  • drugs placed under tongue
  • drugs placed between cheek and gums
  • NOT subject to first-pass effect
  • will be ineffective if swallowed
26
Q

rectal administration

A
  • inserted via suppositories
  • poor absorption, irritation of rectal mucosa
  • partial avoidance of first-pass effect
27
Q

parenteral admin compared to enteral admin

A
  • parenteral methods deliver drugs to the action site more directly
  • quantity of parenteral drug that reaches the site is more predictable
  • not effected by first-pass effect of liver
28
Q

inhalation administration

A
  • drugs in aerosol form
  • drugs diffuse into pulmonary circulation through alveoli
  • commonly used with pulmonary medications and general anesthetics
29
Q

injection administration

A
  • used for systemic or local drugs
  • can be through veins, arteries, skin, muscle, spinal subarachnoid space, bursae
  • IV commonly used in ER because it is fast
30
Q

topical administration

A
  • drug applied to the surface of the skin or mucous membrane
  • used to treat skin conditions
  • not well absorbed across the epidermis
  • includes eye & ear drops
31
Q

transdermal administration

A
  • drugs applied to the surface of the skin
  • designed to be absorbed into skin
  • allows for slow controlled release of drug (medicine patches)
  • absorption & effect of drug depends on local blood flow at the site
  • includes ionto & phonophoresis
32
Q

bioavailability

A

the extent to which the drug reaches the systemic circulation (expressed as a percentage of the amount of drug administered)

33
Q

factors that affect distribution of a drug

A

tissue permeability, blood flow, plasma proteins, subcellular components

34
Q

What is the problem with drugs binding to plasma proteins?

A

drugs can form irreversible bonds with proteins in the bloodstream which renders them essentially ineffective

35
Q

volume of distribution

A

amount of drug administered / concentration of drug in the plasma (used to estimate how well a drug was distributed throughout the body)

36
Q

locations drugs may be stored after being absorbed

A

adipose tissue (most common), bone, muscle, organs

37
Q

controlled-release substances

A

drugs that are designed to have a slower and prolonged absorption from the GI tract or other routes (common in meds for cardiovascular, pain, and parkinson’s)

38
Q

implanted drug devices

A

surgically inserted container in the abdomen that has a reservoir of the drug and releases in small, measured doses on a schedule; can be controlled by remotes

39
Q

two ways of drug elimination

A

biotransformation and excretion

40
Q

biotransformation

A

chemical changes that take place which alter the drug into a metabolite which is inactive

41
Q

site for most drug biotransformation

A

liver

42
Q

methods of drug excretion

A

kidneys (most common), lungs, GI tract, sweat, saliva, breast milk

43
Q

tolerance

A

prolonged use of a drug induces the body to adjust and break down the drug faster

44
Q

clearance

A

elimination of a drug (can be used to describe specific organs or the whole body)

45
Q

half-life

A

the amount of time required for 50% of the drug in the body to be eliminated

46
Q

factors that affect how an individual responds to drugs

A

genetics, disease, drug interactions, age, diet, sex, exercise, smoking, alcohol, obesity, SCI